Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2019

Open Access 01-12-2019 | Study protocol

Eye movement desensitization and reprocessing (EMDR) therapy for posttraumatic stress disorder in adults with serious mental illness within forensic and rehabilitation services: a study protocol for a randomized controlled trial

Authors: Susanna Every-Palmer, Tom Flewett, Shaystah Dean, Oliver Hansby, Atalie Colman, Mark Weatherall, Elliot Bell

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Background

Eye movement desensitization and reprocessing (EMDR) is an evidenced-based treatment for posttraumatic stress disorder (PTSD). Forensic mental health services provide assessment and treatment of people with mental illness and a history of criminal offending, or those who are at risk of offending. Forensic mental health services include high, medium, and low-security inpatient settings as well as prison in-reach and community outpatient services. There is a high prevalence of PTSD in forensic settings and posttraumatic experiences can arise in people who violently offend in the context of serious mental illness (SMI). Successful treatment of PTSD may reduce the risk of relapse and improve clinical outcomes for this population. This study aims to assess the efficacy, risk of harm, and acceptability of EMDR within forensic and rehabilitation mental health services, as compared to treatment as usual (routine care).

Methods

This is a single-blind, randomized controlled trial comparing EMDR therapy to the waiting list (routine care). Adult forensic mental health service users (n = 46) with SMI and meeting the criteria for PTSD will be included in the study. Participants will be randomized after baseline assessment to either treatment as usual plus waiting list for EMDR or to treatment as usual plus EMDR. The EMDR condition comprises nine sessions, around 60 min in length delivered weekly, the first of which is a case conceptualization session. The primary outcomes are clinician and participant-rated symptoms of PTSD, and adverse events. Secondary outcomes include psychotic symptoms, social functioning, level of disability, self-esteem, depressive symptoms, post-trauma cognitions, and broad domains of complex posttraumatic difficulties. A trained assessor blinded to the treatment condition will assess outcomes at baseline, 10 weeks, and 6 months. Additionally, grounded theory qualitative methods will be used to explore participant experience of EMDR for a subset of participants.

Discussion

This study will contribute to the currently limited evidence base for EMDR for PTSD in forensic settings. It is the first randomized clinical trial to assess the efficacy, risk of harm, and acceptability of EMDR for PTSD in people with SMI in either forensic, mental health inpatient, or custodial settings.

Trial registration

Australia and New Zealand Clinical Trials Network, ACTRN12618000683​235. Registered prospectively on 24 April 2018.
Appendix
Available only for authorised users
Footnotes
1
Māori are the indigenous people of New Zealand.
 
Literature
1.
Gray NS, Carman NG, Rogers P, MacCulloch MJ, Hayward P, Snowden RJ. Post-traumatic stress disorder caused in mentally disordered offenders by the committing of a serious violent or sexual offence. J Forens Psychiatry Psychol. 2003;14(1):27–43.CrossRef
2.
3.
Brinded PM, Simpson AI, Laidlaw TM, Fairley N, Malcolm F. Prevalence of psychiatric disorders in New Zealand prisons: a national study. Aust N Z J Psychiatry. 2001;35(2):166–73.PubMedCrossRef
4.
Crisford H, Dare H, Evangeli M. Offence-related posttraumatic stress disorder (PTSD) symptomatology and guilt in mentally disordered violent and sexual offenders. J Forens Psychiatry Psychol. 2008;19(1):86–107.CrossRef
5.
Komarovskaya IA, Booker Loper A, Warren J, Jackson S. Exploring gender differences in trauma exposure and the emergence of symptoms of PTSD among incarcerated men and women. J Forens Psychiatry Psychol. 2011;22(3):395–410.CrossRef
6.
7.
Collier S, Friedman SH. Mental illness among women referred for psychiatric services in a New Zealand women’s prison. Behav Sci Law. 2016;34(4):539–50.PubMedCrossRef
8.
Spitzer C, Chevalier C, Gillner M, Freyberger HJ, Barnow S. Complex posttraumatic stress disorder and child maltreatment in forensic inpatients. J Forens Psychiatry Psychol. 2006;17(2):204–16.CrossRef
9.
Royal Australian New Zealand College of Psychiatrists (RANZCP). The economic cost of serious mental illness and comorbidities in Australia and New Zealand. Melbourne: RANZCP; 2016.
10.
Papanastassiou M, Waldron G, Boyle J, Chesterman LP. Post-traumatic stress disorder in mentally ill perpetrators of homicide. J Forens Psychiatry Psychol. 2004;15(1):66–75.CrossRef
11.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington: American Psychiatric Association; 2013.
12.
13.
14.
World Health Organization. Guidelines for the management of conditions specifically related to stress. Geneva: World Health Organization; 2013.
15.
Shapiro F, Wesselmann D, Mevissen L. Eye movement desensitization and reprocessing therapy (EMDR). In: Landolt M, Cloitre M, Schnyder U, editors. Evidence-Based Treatments for Trauma Related Disorders in Children and Adolescents. Cham: Springer.
16.
van den Berg DP, de Bont PA, van der Vleugel BM, De Roos C, de Jongh A, van Minnen A, van der Gaag M. Trauma-focused treatment in PTSD patients with psychosis: symptom exacerbation, adverse events, and revictimization. Schizophr Bull. 2015;42(3):693–702.PubMedPubMedCentralCrossRef
17.
Kayrouz R, Vrklevski LP. Fatal torment—from psychosis-driven index offence to trauma: a case study in forensic psychotherapy, trauma therapy and matricide. Australas Psychiatry. 2015;23(1):54–8.PubMedCrossRef
18.
Lad S. A case report of treatment of offence related PTSD. J Forens Psychiatry Psychol. 2013;24(6):788–94.CrossRef
19.
Rogers P, Gray NS, Williams T, Kitchiner N. Behavioral treatment of PTSD in a perpetrator of manslaughter: a single case study. J Trauma Stress. 2000;13(3):511–9.PubMedCrossRef
20.
Clark L, Tyler N, Gannon TA, Kingham M. Eye movement desensitisation and reprocessing for offence-related trauma in a mentally disordered sexual offender. J Sex Aggress. 2014;20(2):240–9.CrossRef
21.
Pollock PH. Eye movement desensitization and reprocessing (EMDR) for post-traumatic stress disorder (PTSD) following homicide. J Forens Psychiatry. 2000;11(1):176–84.CrossRef
22.
Fleurkens P, Hendriks L, van Minnen A. Eye Movement Desensitization and Reprocessing (EMDR) in a forensic patient with Posttraumatic Stress Disorder (PTSD) resulting from homicide: a case study. J Forens Psychiatry Psychol. 2018;29(6):901-13.CrossRef
23.
de Bont PA, van den Berg DP, van der Vleugel BM, de Roos C, Mulder CL, Becker ES, de Jongh A, van der Gaag M, van Minnen A. A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials. 2013;14(1):151.PubMedPubMedCentralCrossRef
24.
van den Berg DP, de Bont PA, van der Vleugel BM, de Roos C, de Jongh A, Van Minnen A, van der Gaag M. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. J Am Med Assoc Psychiatry. 2015;72(3):259–67.
25.
van den Berg DPG, de Bont PAJM, van der Vleugel BM, de Roos C, de Jongh A, van Minnen A, van der Gaag M. Trauma-focused treatment in PTSD patients with psychosis: symptom exacerbation, adverse events, and revictimization. Schizophr Bull. 2016;42(3):693–702.PubMedCrossRef
26.
Brewin CR, Rose S, Andrews B, Green J, Tata P, McEvedy C, Turner S, Foa EB. Brief screening instrument for post-traumatic stress disorder. Br J Psychiatry. 2002;181(2):158–62.PubMedCrossRef
27.
Brewin CR. Systematic review of screening instruments for adults at risk of PTSD. J Trauma Stress. 2005;18(1):53–62.PubMedCrossRef
28.
Miller DD. Atypical antipsychotics: sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 2):3.PubMedPubMedCentral
29.
30.
Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a clinician-administered PTSD scale. J Trauma Stress. 1995;8(1):75–90.PubMedCrossRef
31.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed., Text Revision). Washington, DC: American Psychiatric Association; 2000.
32.
Weathers FW, Keane TM, Davidson JR. Clinician-Administered PTSD Scale: a review of the first ten years of research. Depress Anxiety. 2001;13(3):132–56.PubMedCrossRef
33.
Maxfield L, Smyth NJ, Stickgold R. EMDR Fidelity Rating Scale (EFRS); 2018.
34.
Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, Kulkarni J, McGorry P, Nielssen O, Tran N. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410–72.PubMedCrossRef
35.
Lobbestael J, Arntz A, Harkema-Schouten P, Bernstein D. Development and psychometric evaluation of a new assessment method for childhood maltreatment experiences: the Interview for Traumatic Events in Childhood (ITEC). Child Abuse Negl. 2009;33(8):505–17.PubMedCrossRef
36.
de Jongh A, ten Broeke E, Meijer S. Two method approach: a case conceptualization model in the context of EMDR. J EMDR Pract Res. 2010;4(1):12.CrossRef
37.
Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, Keane TM, Marx BP. The Clinician-Administered PTSD Scale for DSM–5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383.PubMedCrossRef
38.
Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress. 1993;6(4):459–73.CrossRef
39.
Wohlfarth TD, van den Brink W, Winkel FW, ter Smitten M. Screening for posttraumatic stress disorder: an evaluation of two self-report scales among crime victims. Psychol Assess. 2003;15(1):101.PubMedCrossRef
40.
Kilcommons AM, Morrison A. Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatr Scand. 2005;112(5):351–9.PubMedCrossRef
41.
Milosevic I, Levy HC, Alcolado GM, Radomsky AS. The treatment acceptability/adherence scale: moving beyond the assessment of treatment effectiveness. Cogn Behav Ther. 2015;44(6):456–69.PubMedCrossRef
42.
Briere JN, Scott C. Principles of trauma therapy: a guide to symptoms, evaluation, and treatment (DSM-5 update). Los Angeles: Sage Publications; 2014.
43.
Foa EB, Ehlers A, Clark DM, Tolin DF, Orsillo SM. The Posttraumatic Cognitions Inventory (PTCI): development and validation. Psychol Assess. 1999;11(3):303.CrossRef
44.
Briere J. Trauma Symptom Inventory-2: professional manual. Lutz: Psychological Assessment Resources; 2011.
45.
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996
46.
Quilty LC, Zhang KA, Bagby RM. The latent symptom structure of the Beck Depression Inventory–II in outpatients with major depression. Psychol Assess. 2010;22(3):603.PubMedCrossRef
47.
Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, Korff M, Pull C. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88:815–23.PubMedPubMedCentralCrossRef
48.
Gold LH. DSM-5 and the assessment of functioning: the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). J Am Acad Psychiatry Law. 2014;42(2):173–81.PubMed
49.
Haddock G, McCarron J, Tarrier N, Faragher E.B. Scale to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879–889.PubMedCrossRef
50.
Birchwood M, Smith JO, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990;157(6):853–9.PubMedCrossRef
51.
Burns T, Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr Scand. 2007;116(6):403–18.PubMedCrossRef
52.
Rosenberg M. Rosenberg Self-Esteem Scale (RSE). Acceptance and commitment therapy measures package, vol. 61; 1965. p. 52.
53.
Sinclair SJ, Blais MA, Gansler DA, Sandberg E, Bistis K, LoCicero A. Psychometric properties of the Rosenberg Self-Esteem Scale: overall and across demographic groups living within the United States. Eval Health Prof. 2010;33(1):56–80.PubMedCrossRef
54.
Every-Palmer S, Ellis PM, Nowitz M, Stanley J, Grant E, Huthwaite M, Dunn H. The Porirua Protocol in the treatment of clozapine-induced gastrointestinal hypomotility and constipation: a pre-and post-treatment study. CNS Drugs. 2017;31(1):75–85.PubMedCrossRef
55.
Every-Palmer S, Inns SJ, Grant E, Ellis PM. Effects of clozapine on the gut: cross-sectional study of delayed gastric emptying and small and large intestinal dysmotility. CNS Drugs. 2019;33(1):81–91.PubMedCrossRef
56.
Metadata
Title
Eye movement desensitization and reprocessing (EMDR) therapy for posttraumatic stress disorder in adults with serious mental illness within forensic and rehabilitation services: a study protocol for a randomized controlled trial
Authors
Susanna Every-Palmer
Tom Flewett
Shaystah Dean
Oliver Hansby
Atalie Colman
Mark Weatherall
Elliot Bell
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3760-2

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue

Research

Nurse-led, telephone-based secondary preventive follow-up benefits stroke/TIA patients with low education: a randomized controlled trial sub-study

Study protocol

Effects of acupuncture on the hypothalamus-pituitary-adrenal axis in chronic insomnia patients: a study protocol for a randomized controlled trial

Research

Promoting physical activity among community groups of older women in socio-economically disadvantaged areas: randomised feasibility study

Study protocol

The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial

Study protocol

Effects of electroacupuncture frequencies on chronic low back pain in older adults: triple-blind, 12-months protocol for a randomized controlled trial

Commentary

Reducing research waste by promoting informed responses to invitations to participate in clinical trials